Long-Term Efficacy of Atenolol for Atrioventricular Reciprocating Tachycardia in Children Less Than 5 Years Old

@article{Ko2003LongTermEO,
  title={Long-Term Efficacy of Atenolol for Atrioventricular Reciprocating Tachycardia in Children Less Than 5 Years Old},
  author={Jun Kyung Ko and Ji Eun Ban and Young Huwe Kim and In Sook Park},
  journal={Pediatric Cardiology},
  year={2003},
  volume={25},
  pages={97-101}
}
Atrioventricular reciprocating tachycardia (AVRT) using an accessory pathway is the most common supraventricular tachycardia observed in infancy and childhood. There is a general agreement to treat children older than 5 years who are on a potentially long-term antiarrhythmic agent with radiofrequency catheter ablation. Atenolol, a relatively long-acting and cardioselective β-adrenoceptor blocker, has been used to control the various types of supraventricular tachycardia in children and adults… CONTINUE READING